Katja D.
- Country
- Germany
- Department
- Klinik fuer Gastroenterologie, Hepatologie und Endokrinologie
Research Overview
- A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
- Evaluation of Efficacy and Safety of VIR-2218 (Elebsiran) and VIR-3434 (Tobevibart) in Chronic Hepatitis D Virus Infection
- Efficacy and Safety Evaluation of Tobevibart and Elebsiran in Patients with Chronic Hepatitis D Virus Infection
Data & Insights
Has run more than one trial at 33 of 108 partner sites.
Specializations
Hepatology Research
This investigator specializes in advanced treatments for chronic viral hepatitis, with particular emphasis on hepatitis D virus (HDV) infections. Their research encompasses innovative therapeutic approaches for managing chronic liver conditions.
- Chronic HDV Management
- Viral Hepatitis Therapeutics
- Liver Disease Progression
Their work involves evaluating novel antiviral agents including bulevirtide and experimental combinations for hepatitis treatment.
Clinical Outcomes
The investigator focuses on studying long-term clinical outcomes in patients with chronic viral infections. Their research examines the progression of liver disease and treatment effectiveness in real-world settings.
- Disease Progression Monitoring
- Treatment Response Assessment
- Clinical Event Analysis
Key areas include tracking liver-related events and evaluating therapeutic responses in chronic hepatitis patients.
Drug Safety Research
The investigator conducts comprehensive evaluation of treatment safety profiles in hepatitis therapy. Their work includes monitoring patient responses to investigational treatments.
- Adverse Event Assessment
- Safety Monitoring
- Treatment Tolerability
Research includes systematic documentation of treatment-emergent adverse events and serious adverse events in clinical settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.